Bionomics is an Australian clinical stage bio-pharmaceutical company that has focused on two scientific areas that present blockbuster drug opportunities for investors.
Central Nervous System:
BNC210: BNO’s lead candidate is in development for the treatment of anxiety disorders and conditions with co-morbid anxiety including depression and Post-Traumatic Stress Disorder (PTSD).
